Tudor Investment Corp
KALA icon

Tudor Investment Corp’s KALA BIO KALA Stock Holding History

Tudor Investment Corp’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5
Closed -$63K – 2632
2021
Q2 		$63K Buy
+5
New +$78.6K ﹤0.01% 1545
2020
Q3 		– Sell
-11
Closed -$278K – 1426
2020
Q2 		$278K Sell
11
-8
-42% -$227K 0.01% 909
2020
Q1 		$420K Buy
+19
New +$304K 0.04% 558

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Tudor Investment Corp's KALA Position: Q3 2021 in Review

Tudor Investment Corp sold out of KALA BIO (KALA) in Q3 2021, closing a stake of 5 shares — an estimated $63K sold.

Tudor Investment Corp first reported a position in KALA in Q1 2020 and held it in 3 quarters. The position peaked at $420K in Q1 2020. 99 funds tracked by Wall St. Rank hold KALA as of Q3 2021.

  • Tudor Investment Corp reported no remaining KALA BIO position as of Q3 2021 after selling out during the quarter.
  • Tudor Investment Corp sold 5 KALA BIO shares in Q3 2021, an estimated $63K.
  • Tudor Investment Corp first reported a position in KALA BIO in Q1 2020 and held it in 3 quarters.
  • Tudor Investment Corp's KALA BIO position peaked at $420K in Q1 2020.
  • 99 funds tracked by Wall St. Rank held KALA BIO as of Q3 2021.

Based on Tudor Investment Corp's 13F filing for Q3 2021, filed 15 Nov 2021.